On occasion, your healthcare provider may recommend Actemra for something other than rheumatoid arthritis. This medication has been approved in Japan for the treatment of Castleman's disease (a rare condition involving noncancerous tumors) since 2005, although using Actemra for this reason in the United States is still considered an off-label practice.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click